Ovarian cancer patients with molecular subtypes benefit from bevacizumab
Molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.
View ArticleFCVB 2014 to feature cutting edge research in basic cardiovascular science
Cutting edge research in basic cardiovascular science will be presented at Frontiers in CardioVascular Biology (FCVB) 2014, held 4-6 July at the Palau de Congressos de Catalunya in Barcelona, Spain.
View ArticleBayer HealthCare seeks EU marketing authorization of EYLEA for macular edema...
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the...
View ArticleCompound developed as cholesterol-fighting molecule can kill cancerous cells
Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of breast cancer, but also can kill the...
View ArticleResearchers discover crucial process that regulates development of blood vessels
Biologists at The Scripps Research Institute (TSRI) have discovered a crucial process that regulates the development of blood vessels.
View ArticleNew treatment for ovarian cancer can improve response rates
Doctors at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix reported today in Lancet Oncology that a new treatment for ovarian cancer can improve response...
View ArticleNIH receives $10 million grant for research on breast cancer metastasis
The American Cancer Society predicts that 40,000 American women will die from breast cancer this year. Most of those deaths will occur due to cells from the primary tumor that spread to other parts of...
View ArticleOverview of cancer cytokines therapy market
Cytokines, a major group in the protein therapeutics umbrella, are known to be soluble extracellular proteins or glycoproteins which are crucial intercellular regulators, having the capacity to...
View ArticleCardium reports positive results from Generx Ad5FGF-4 Phase 3 study for...
Taxus Cardium Pharmaceuticals Group Inc. will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international...
View ArticleMetabolic pathway genes linked to AMD and choroidal vasculopathy
The cholesteryl ester transfer protein gene appears to increase susceptibility to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy, research shows.
View ArticleMayo Clinic researchers uncover 31 genes key to clear cell renal cell carcinoma
A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the...
View ArticleResearchers discover mechanical threshold that regulates angiogenesis
Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is essential to the body's development. As organs grow, vascular networks must grow with them to feed new cells and remove their...
View ArticleBayer announces Health Canada approval of Nexavar for differentiated thyroid...
Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma (DTC),...
View ArticleResearch into cell metabolism could open new therapeutic avenues for...
More scientific research into the metabolism of stromal support cells and immune cells - and the role of the metabolism of these cell types in the development of diseases - could open new therapeutic...
View ArticleResearchers create combination drug that controls both tumor growth and...
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar...
View ArticleMarker identified for population of renal cancer cells with stem-cell-like...
Researchers have identified a population of clear cell renal cell carcinoma cells positive for the CTR2 marker that possess some stem-cell-like features and are able to induce an angiogenic response in...
View ArticleMarker identified for population of renal cancer cells with stem-cell-like...
Researchers have identified a population of clear cell renal cell carcinoma cells positive for the CTR2 marker that possess some stem-cell-like features and are able to induce an angiogenic response in...
View ArticleTargeting CXCR4–CXCL12–CXCR7 axis combats mTOR inhibitor resistance in renal...
There is considerable crosstalk between the CXCR4–CXCL12–CXCR7 axis and the mammalian target of rapamycin pathway in human renal cell carcinoma, and targeting the axis may overcome drug resistance to...
View ArticleAMSBIO-Trevigen prize winner announced
AMSBIO, regular sponsor of the annual Beatson International Cancer Conference announces that the winner of the AMSBIO-Trevigen prize for the best poster was Katarzyna Grzes - a PhD researcher...
View ArticleKinex receives FDA approval to begin Phase I study of KX2-391 Ointment for...
Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's...
View Article
